Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Mantle-Cell 39Waldenstrom Macroglobulinemia 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 14Recurrence 10Lymphoma, B-Cell, Marginal Zone 10Leukemia 9Lymphoma, B-Cell 8Lymphoma 8Neoplasms 7Lymphoma, Non-Hodgkin 5Leukemia, Prolymphocytic 4Hodgkin Disease 4Multiple Myeloma 3Leukemia, Myeloid, Acute 3Leukemia, B-Cell 3Hematologic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Glioblastoma 2Chromosome 17 deletion 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Primary Central Nervous System Lymphoma (PCNSL) 1

Interventions

Cyclophosphamide 9Temozolomide 7Radiotherapy 6Magnetic Resonance Spectroscopy 5Filgrastim 5Cisplatin 5Carboplatin 5antineoplaston AS 2-1 4antineoplaston A10 4Etoposide 4sargramostim 3Vincristine 3Thiotepa 3Melphalan 3Automobiles 3fludarabine 2aldesleukin 2Thalidomide 2Surveys and Questionnaires 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Gadolinium DTPA 2Eflornithine 2Donepezil 2Carmustine 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive × ibrutinib × Clear all
NCT05106296 2026-01-09

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Augusta University

Phase 1 Recruiting
37 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡